BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24774101)

  • 1. Markov modeling and discrete event simulation in health care: a systematic comparison.
    Standfield L; Comans T; Scuffham P
    Int J Technol Assess Health Care; 2014 Apr; 30(2):165-72. PubMed ID: 24774101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An empirical comparison of Markov cohort modeling and discrete event simulation in a capacity-constrained health care setting.
    Standfield LB; Comans TA; Scuffham PA
    Eur J Health Econ; 2017 Jan; 18(1):33-47. PubMed ID: 26715578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matching the model with the evidence: comparing discrete event simulation and state-transition modeling for time-to-event predictions in a cost-effectiveness analysis of treatment in metastatic colorectal cancer patients.
    Degeling K; Franken MD; May AM; van Oijen MGH; Koopman M; Punt CJA; IJzerman MJ; Koffijberg H
    Cancer Epidemiol; 2018 Dec; 57():60-67. PubMed ID: 30317148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling rheumatoid arthritis using different techniques - a review of model construction and results.
    Scholz S; Mittendorf T
    Health Econ Rev; 2014 Dec; 4(1):18. PubMed ID: 26208921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulation.
    Karnon J
    Health Econ; 2003 Oct; 12(10):837-48. PubMed ID: 14508868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrete Event Simulation for Decision Modeling in Health Care: Lessons from Abdominal Aortic Aneurysm Screening.
    Glover MJ; Jones E; Masconi KL; Sweeting MJ; Thompson SG; ;
    Med Decis Making; 2018 May; 38(4):439-451. PubMed ID: 31665967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging methods in economic modeling of imaging costs and outcomes a short report on discrete event simulation.
    Hollingworth W; Spackman DE
    Acad Radiol; 2007 Apr; 14(4):406-10. PubMed ID: 17368208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Efficiency of Increasing the Capacity of Physiotherapy Screening Clinics or Traditional Medical Services to Address Unmet Demand in Orthopaedic Outpatients: A Practical Application of Discrete Event Simulation with Dynamic Queuing.
    Standfield L; Comans T; Raymer M; O'Leary S; Moretto N; Scuffham P
    Appl Health Econ Health Policy; 2016 Aug; 14(4):479-491. PubMed ID: 27116359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrete event simulation: the preferred technique for health economic evaluations?
    Caro JJ; Möller J; Getsios D
    Value Health; 2010 Dec; 13(8):1056-60. PubMed ID: 20825626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discounting in cost-utility analysis of healthcare interventions: reassessing current practice.
    Cohen BJ
    Pharmacoeconomics; 2003; 21(2):75-87. PubMed ID: 12515570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using whole disease modeling to inform resource allocation decisions: economic evaluation of a clinical guideline for colorectal cancer using a single model.
    Tappenden P; Chilcott J; Brennan A; Squires H; Glynne-Jones R; Tappenden J
    Value Health; 2013 Jun; 16(4):542-53. PubMed ID: 23796288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling hard clinical end-point data in economic analyses.
    Kansal AR; Zheng Y; Palencia R; Ruffolo A; Hass B; Sorensen SV
    J Med Econ; 2013 Nov; 16(11):1327-43. PubMed ID: 24032651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tutorial in medical decision modeling incorporating waiting lines and queues using discrete event simulation.
    Jahn B; Theurl E; Siebert U; Pfeiffer KP
    Value Health; 2010; 13(4):501-6. PubMed ID: 20345550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-minimization comparison of darunavir plus ritonavir and lopinavir/ritonavir in HIV-1 infected treatment-naïve women of childbearing age.
    Möller J; Desai K; Simpson K; Baran RW; Van de Steen O; Dietz B; Gooch K
    J Med Econ; 2014 Apr; 17(4):250-8. PubMed ID: 24351091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--4.
    Karnon J; Stahl J; Brennan A; Caro JJ; Mar J; Möller J;
    Value Health; 2012; 15(6):821-7. PubMed ID: 22999131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the value for money of changing clinical practice change: a stochastic application in diabetes care.
    Hoomans T; Abrams KR; Ament AJ; Evers SM; Severens JL
    Med Care; 2009 Oct; 47(10):1053-61. PubMed ID: 19648827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
    Adang E; Voordijk L; Jan van der Wilt G; Ament A
    Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of Markov Queuing Model in Hospital Bed Resource Allocation.
    Wu J; Chen B; Wu D; Wang J; Peng X; Xu X
    J Healthc Eng; 2020; 2020():6630885. PubMed ID: 33489058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial intelligence framework for simulating clinical decision-making: a Markov decision process approach.
    Bennett CC; Hauser K
    Artif Intell Med; 2013 Jan; 57(1):9-19. PubMed ID: 23287490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A computer simulation model of the natural history and economic impact of chronic obstructive pulmonary disease.
    Borg S; Ericsson A; Wedzicha J; Gulsvik A; Lundbäck B; Donaldson GC; Sullivan SD
    Value Health; 2004; 7(2):153-67. PubMed ID: 15164805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.